Predictive Oncology

Predictive Oncology provides expert insights on drug discovery and development.

The webinar covers 3D disease models in drug development and a patient-derived platform that mimics human tissue architecture by organ and disease type, with reported correlation to clinical response.

The webinar discusses how 3D cell culture addresses limitations of traditional 2D culture in predicting the therapeutic potential of pharmaceutical compounds. It describes the Reconstructed Lung 3D culture platform (r-Lung) for testing anticancer agents in high-throughput screening.

The webinar says standard approaches to evaluating drug efficacy may not reflect human biology, disease processes, or treatment response. It discusses the use of tumor-specific 3D culture models.

Predictive Oncology’s digital newsroom provides links to announcements, press coverage, photos, and videos.

Predictive Oncology is a science-driven company focused on oncology drug discovery. It offers solutions for the biopharma industry and integrates scientific rigor with machine learning.

The page lists Pennsylvania headquarters at 91 43rd Street, Suite 110, Pittsburgh, PA 15201, and phone number (412) 432-1500.

Predictive Oncology integrates scientific rigor with machine learning and collaborates with partners in biopharma.

Predictive Oncology Inc.’s privacy policy explains how the company and its subsidiaries collect, use, and handle personally identifiable information shared by individuals.